send link to app

CMPL


4.0 ( 0 ratings )
Medical
Desenvolvedor: Novartis Pharma AG
Darmowy

The CMpL app allows to perform a Chronic Myeloid Leukemia (CML) risk assessment and response tracking. In addition, the app gives an easy access to European LeukemiaNet (ELN) recommendations and other publications.

Risk Calculator
Calculates the Sokal risk score

Response Tracking
Benchmarks response in function of data such as TKI medication, treatment duration and result

Publications
ELN Recommendations, results of ERNESTnd trial with different sokal risk scores and more